OncoPro Lung Basic Panel Test: Comprehensive Lung Cancer Genetic Profiling
Introduction to OncoPro Lung Basic Panel
The OncoPro Lung Basic Panel represents a breakthrough in personalized lung cancer care, offering comprehensive genetic analysis specifically designed for patients diagnosed with lung cancer. This advanced diagnostic panel utilizes cutting-edge molecular techniques to identify key genetic mutations that drive cancer growth, providing oncologists with critical information for targeted treatment selection. By analyzing specific genetic markers, this test helps transform standard cancer care into precision medicine, ensuring each patient receives the most effective therapy based on their unique genetic profile.
What the OncoPro Lung Basic Panel Measures
This comprehensive panel analyzes three essential genetic markers crucial for lung cancer treatment decisions:
- ALK1-FISH Analysis: Detects anaplastic lymphoma kinase gene rearrangements, which are present in approximately 3-7% of non-small cell lung cancers
- ROS1-FISH Analysis: Identifies ROS1 gene fusions found in 1-2% of non-small cell lung cancer patients
- EGFR Mutation Analysis: Screens for epidermal growth factor receptor mutations, present in 10-15% of lung adenocarcinoma cases
Who Should Consider This Test
The OncoPro Lung Basic Panel is recommended for individuals who:
- Have been diagnosed with non-small cell lung cancer (NSCLC)
- Are experiencing persistent cough, chest pain, or breathing difficulties
- Have unexplained weight loss or fatigue associated with respiratory symptoms
- Have a family history of lung cancer or genetic predisposition
- Are current or former smokers with concerning symptoms
- Need guidance for targeted therapy selection
Benefits of Taking the OncoPro Lung Basic Panel
- Personalized Treatment: Identifies specific genetic mutations to guide targeted therapy selection
- Improved Outcomes: Patients with targetable mutations often experience better response rates and survival
- Reduced Side Effects: Targeted therapies typically have fewer side effects than traditional chemotherapy
- Comprehensive Analysis: Three critical biomarkers analyzed in a single test
- Rapid Results: Turnaround time of 3-5 business days for timely treatment decisions
- Cost-Effective: Comprehensive testing at an affordable price point
Understanding Your Test Results
Your OncoPro Lung Basic Panel results will provide detailed information about the presence or absence of specific genetic mutations:
- Positive Results: Indicate the presence of targetable genetic alterations, making you eligible for specific targeted therapies
- Negative Results: Show no detectable mutations in the tested genes, suggesting alternative treatment approaches may be more appropriate
- Interpretation: All results should be discussed with your oncologist who will explain the clinical implications and recommend appropriate next steps
- Treatment Guidance: Positive findings can lead to FDA-approved targeted therapies with proven efficacy
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| OncoPro Lung Basic Panel Test | $352 USD | $390 USD |
Nationwide Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible genetic testing services for patients throughout the country.
Book Your OncoPro Lung Basic Panel Today
Take control of your lung cancer treatment journey with comprehensive genetic profiling. Our experienced team is ready to assist you with scheduling and answer any questions about the testing process. Contact us today to book your appointment and begin your personalized cancer care pathway.
Call or WhatsApp: +1(267) 388-9828
Sample Requirements and Processing
The OncoPro Lung Basic Panel requires submission of a formalin-fixed paraffin-embedded tissue block containing at least 10% tumor cells. Samples should be shipped at room temperature, and the completed Chromosome & FISH Analysis Requisition Form (Form 17) is mandatory for processing. Testing is performed using advanced FISH and Sanger Sequencing methodologies to ensure accurate and reliable results.
Turnaround Time
For optimal processing, samples should be submitted on Monday or Thursday by 9:00 AM. Reports are typically available on the following Friday or Tuesday, providing rapid results to support timely treatment decisions.
